The Efficacy of Interferon(IFN)-![]() ![]() |
Park, Joo Hun
(Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center)
Oh, Yeon Mok (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Shim, Tae Sun (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Lim, Chae-Man (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Koh, Younsuck (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Lee, Sang-Do (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Kim, Woo Sung (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Kim, Won Dong (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) Kim, Dong Soon (Division of Pulmonary and Critical Care Medicine, University of Ulsan, College of Medicine, Asan Medical Center) |
1 | Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992;88:280-87 |
2 | Specks U, Nerlich A, Colby TV, Wiest I, Timpl R. Increased expression of type VI collagen in lung fibrosis. Am J Respir Crit Care Med 1995;15:1956-64 |
3 | Van Zandwijk N, Groen H, Postmus P, Burghouts J, Velde G, Ardizzoni A, et al. Role of recombinant interferon-gamma main tenance in responding patients with small cell lung cancer, a randomized phase III study. Eur J Cancer 1997;33:1759–66 |
4 | Eickelberg O, Pansky A, Koehler E, Bihl M, Tamm M, Hildebrand P, et al. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J 2001;15:797–806 |
5 | Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypothesis about its pathogenesis and implication for therapy. Ann Intern Med 2001:345:517-25 |
6 | 김동순. 특발성 폐섬유화증의 치료. 결핵 및 호흡기 질환 2003;54:260-73 |
7 | Shaw E, Deming R, Creagan E, Nair S, Su J, Levitt R, et al. Pilot study of human recombinant interferon gamma and accelerated hyper fractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995;31:827–31 |
8 | Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990;97:1439-45 |
9 | American Thoracic Society/European Respiratory Society. 2002. International multidisciplinary consensus classification of idiopathic interstitial pneumonias: general principles and recommendations. Am J Respir Crit Care Med 165:277–304 |
10 | Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995;21:791–808 |
11 |
Honor |
12 | Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992;88:280-87 |
13 |
Ziesche R, Kink E, Herold C, Podolsky A, Block LH. Therapy of chronic interstitial lung disease with a combination of interferon- |
14 | Majumdar S, Li D, Ansari T, et al. Tissue cytokine profiles of cryptogenic fibrosing alveolitis (CFA) and fibrosing alveolitis as sociated with systemic sclerosis (FASSc) are distinct: a quantitative in situ study of open lung biopsies. Eur Respir J 1999;14:251-57 |
15 | Redman B, Flaherty L, Chou T, Al-Katid A, Kraut M, Martino S, et al. A phase I trial of recombinant interferon-gamma combined with recombinant interleukin-2 in patients with cancer. J Clin Oncol 1990;8:1269–76 |
16 | Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of longterm treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264–69 |
17 | Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–25 |
18 |
박주헌, M. Kitaichi, 염호기 |
19 | Selman moises.A dark side of interferonegamma in the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 2003;167:945-47 |
20 | International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000;161:646-64 |
![]() |